A consideration may be that modulation of hepatic de novo lipogenesis via the SREBP-1c and DGAT-2 pathways by Jiangzhi Capsule is insufficient to improve fructose-induced hypertriglyceridemia. Here, SREBF1 is linked to hypertriglyceridemia.